Scandinavian epidemiological research in gastroenterology and hepatology

References

• JMyren, EGjone, JNHertzber, ORygvold, LSSemb, BFretheim. Epidemiology of ulcerative colitis and regional enterocolitis (Crohns Disease) in Norway. Scand J Gastroenterol 1971;6:511–14.
   PubMed Web of Science ®Google Scholar
• BJNorlen, UKrause, LBerman. An epidemiological study of crohns disease. Scand J Gastroenterol 1970;5:385–90.
   PubMed Web of Science ®Google Scholar
• LBergman, UKrause. The incidence of Crohn’s disease in central Sweden. Scand J Gastroenterol 1975;10:725–9.
   PubMed Web of Science ®Google Scholar
• FBrahme, CLindström, AWenckert. Crohn’s disease in a defined population. An epidemiological study of incidence, prevalence, mortality, and secular trends in the city of Malmö, Sweden. Gastroenterology 1975;69:342–51.
   PubMed Web of Science ®Google Scholar
• GHellers. Crohn’s disease in Stockholm county 1955-1974. A study of epidemiology, results of surgical treatment and long-term prognosis. Acta Chir Scand Suppl 1979;490:1–84.
   PubMedGoogle Scholar
• VBinder, HBoth, PKHansen, CHenriksen, SKreiner, KTorp-Pedersen. Incidence and prevalence of ulcerative colitis and Crohn’s disease in the County of Copenhagen, 1962 to 1978. Gastroenterology 1982;83:563.
   PubMed Web of Science ®Google Scholar
• CHendriksen, VBinder. Social prognosis in patients with ulcerative colitis. Br Med J 1980;281:581–3.
   PubMed Web of Science ®Google Scholar
• SMSamuelsson. Ulcerös colit och proctit. Uppsala. Deparment of Social Medicine, University of Uppsala; Thesis 1976.
   Google Scholar
• ARönnblom, SMSamuelsson, AEkbom. Ulcerative colitis in the county of Uppsala 1945-2007: incidence and clinical characteristics. J Crohns Colitis 2010;4:532–6.
   PubMed Web of Science ®Google Scholar
• AEkbom, CHelmick, MZack, HOAdami. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology 1991;100:350–8.
   PubMed Web of Science ®Google Scholar
• RESedlack, FTNobrega, LTKurland, WGSauer. Inflammatory colon disease in Rochester, Minnesota, 1935-1964. Gastroenterology 1972;62:935–41.
   PubMed Web of Science ®Google Scholar
• BNordenvall, OBroström, MBerglund, UMonsen, JNordenström, JSörstad, et al. Incidence of ulcerative colitis in Stockholm County 1955-1979. Scand J Gastroenterol 1985;20:783–90.
   PubMed Web of Science ®Google Scholar
• JStewénius, IAdnerhill, GEkelund, CHFlorén, FTFork, LJanzon, et al. Ulcerative colitis and indeterminate colitis in the city of Malmö, Sweden. A 25-year incidence study. Scand J Gastroenterol 1995;30:38–43.
   PubMed Web of Science ®Google Scholar
• CTysk, GJärnerot. Ulcerative proctocolitis in Orebro, Sweden. A retrospective epidemiologic study, 1963-1987. Scand J Gastroenterol 1992;27:945–50.
   PubMed Web of Science ®Google Scholar
• ELindberg, GJärnerot. The incidence of Crohn’s disease is not decreasing in Sweden. Scand J Gastroenterol 1991;26:495–500.
   PubMed Web of Science ®Google Scholar
• HNyhlin, ADanielsson. Incidence of Crohn’s disease in a defined population in northern Sweden, 1974-1981. Scand J Gastroenterol 1986;21:1185–92.
   PubMed Web of Science ®Google Scholar
• LHalme, Kvon Smitten, AHusa. The incidence of Crohn’s disease in the Helsinki metropolitan area during 1975-1985. Ann Chir Gynaecol 1989;78:115–19.
   PubMedGoogle Scholar
• AJussila, LJVirta, HKautiainen, MRekiaro, UNieminen, MAFärkkilä. Increasing incidence of inflammatory bowel diseases between 2000 and 2007: a nationwide register study in Finland. Inflamm Bowel Dis 2012;18:555–61.
   PubMed Web of Science ®Google Scholar
• JHaapamäki, UTurunen, RPRoine, MAFärkkilä, PEArkkila. Finnish patients with inflammatory bowel disease have fewer symptoms and are more satisfied with their treatment than patients in the previous European survey. Scand J Gastroenterol 2008;43:821–30.
   PubMed Web of Science ®Google Scholar
• LHalme, UTurunen, THeliö, PPaavola, TWalle, AMiettinen, et al. Familial and sporadic inflammatory bowel disease: comparison of clinical features and serological markers in a genetically homogeneous population. Scand J Gastroenterol 2002;37:692–8.
   PubMed Web of Science ®Google Scholar
• KHaug, ESchrumpf, JFHalvorsen, GFluge, EHamre, THamre, et al. Epidemiology of Crohn’s disease in western Norway. Study group of Inflammatory Bowel Disease in Western Norway. Scand J Gastroenterol 1989;24:1271–5.
   PubMed Web of Science ®Google Scholar
• SKildebo, RBreckan, KNordgaard, PGBurhol, RJorde. The incidence of Crohn’s disease in northern Norway from 1983 to 1986. Northern Norway Gastroenterology Society. Scand J Gastroenterol 1989;24:1265–70.
   PubMed Web of Science ®Google Scholar
• SKildebo, KNordgaard, OAronsen, RBreckan, PGBurhol, RJorde. The incidence of ulcerative colitis in Northern Norway from 1983 to 1986. The Northern Norwegian Gastroenterology Society. Scand J Gastroenterol 1990;25:890–6.
   PubMed Web of Science ®Google Scholar
• ELangholz, PMunkholm, OHNielsen, SKreiner, VBinder. Incidence and prevalence of ulcerative colitis in Copenhagen county from 1962 to 1987. Scand J Gastroenterol 1991;26:1247–56.
   PubMed Web of Science ®Google Scholar
• PMunkholm, ELangholz, OHNielsen, SKreiner, VBinder. Incidence and prevalence of Crohn’s disease in the county of Copenhagen, 1962-87: a sixfold increase in incidence. Scand J Gastroenterol 1992;27:609–14.
   PubMed Web of Science ®Google Scholar
• SBjörnsson. Inflammatory bowel disease in Iceland during a 30-year period, 1950-1979. Scand J Gastroenterol Suppl 1989;170:47–9; discussion 50-5.
   PubMedGoogle Scholar
• SBjörnsson, JHJohannsson, EOddsson. Inflammatory bowel disease in Iceland, 1980-89. A retrospective nationwide epidemiologic study. Scand J Gastroenterol 1998;33:71–7.
   PubMed Web of Science ®Google Scholar
• SBjörnsson, JHJóhannsson. Inflammatory bowel disease in Iceland, 1990-1994: a prospective, nationwide, epidemiological study. Eur J Gastroenterol Hepatol 2000;12:31–8.
   PubMed Web of Science ®Google Scholar
• JBerner, TKiaer. Ulcerative colitis and Crohn’s disease on the Faroe Islands 1964-83. A retrospective epidemiological survey. Scand J Gastroenterol 1986;21:188–92.
   PubMed Web of Science ®Google Scholar
• FRóin, JRóin. Inflammatory bowel disease of the Faroe Islands, 1981-1988. A prospective epidemiologic study: primary report. Scand J Gastroenterol Suppl 1989;170:44–6.
   PubMedGoogle Scholar
• SShivananda, JLennard-Jones, RLogan, NFear, APrice, LCarpenter, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996;39:690–7.
   PubMed Web of Science ®Google Scholar
• BMoum, MHVatn, AEkbom, EAadland, OFausa, ILygren, et al. Incidence of Crohn’s disease in four counties in southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol 1996;31:355–61.
   PubMed Web of Science ®Google Scholar
• BMoum, MHVatn, AEkbom, EAadland, OFausa, ILygren, et al. Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol 1996;31:362–6.
   PubMed Web of Science ®Google Scholar
• UKrause, SEjerblad, LBergman. Crohn’s disease. A long-term study of the clinical course in 186 patients. Scand J Gastroenterol 1985;20:516–24.
   PubMed Web of Science ®Google Scholar
• HBoth, KTorp-Pedersen, SKreiner, CHenriksen, VBinder. Clinical appearance at diagnosis of ulcerative colitis and Crohn’s disease in a regional patients group. Scand J Gastroenterol 1983;18:987–91.
   PubMed Web of Science ®Google Scholar
• VBinder, CHendriksen, SKreiner. Prognosis in Crohn’s disease—based on results from a regional patient group from the county of Copenhagen. Gut 1985;26:146–50.
   PubMed Web of Science ®Google Scholar
• CHendriksen, SKreiner, VBinder. Long term prognosis in ulcerative colitis–based on results from a regional patient group from the county of Copenhagen. Gut 1985;26:158–63.
   PubMed Web of Science ®Google Scholar
• BMoum, AEkbom, MHVatn, EAadland, JSauar, ILygren, et al. Clinical course during the 1st year after diagnosis in ulcerative colitis and Crohn’s disease. Results of a large, prospective population-based study in southeastern Norway, 1990-93. Scand J Gastroenterol 1997;32:1005–12.
   PubMed Web of Science ®Google Scholar
• TBernklev, JJahnsen, EAadland, JSauar, TSchulz, ILygren, IBSEN Study Group. Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis. Scand J Gastroenterol 2004;39:365–73.
   PubMed Web of Science ®Google Scholar
• MHenriksen, JJahnsen, ILygren, JSauar, TSchulz, NStray, Ibsen Study Group. Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study). Scand J Gastroenterol 2006;41:1037–43.
   PubMed Web of Science ®Google Scholar
• MHenriksen, JJahnsen, ILygren, EAadland, TSchulz, MHVatn, Ibsen Study Group. Clinical course in Crohn’s disease: results of a five-year population-based follow-up study (the IBSEN study). Scand J Gastroenterol 2007;42:602–10.
   PubMed Web of Science ®Google Scholar
• ICSolberg, ILygren, JJahnsen, EAadland, OHøie, MCvancarova, IBSEN Study Group. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol 2009;44:431–40.
   PubMed Web of Science ®Google Scholar
• PMunkholm, ELangholz, MDavidsen, VBinder. Disease activity courses in a regional cohort of Crohn’s disease patients. Scand J Gastroenterol 1995;30:699–706.
   PubMed Web of Science ®Google Scholar
• ELangholz, PMunkholm, MDavidsen, VBinder. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994;107:3–11.
   PubMed Web of Science ®Google Scholar
• BMoum, EAadland, AEkbom, MHVatn. Seasonal variations in the onset of ulcerative colitis. Gut 1996;38:376–8.
   PubMed Web of Science ®Google Scholar
• CTysk, GJärnerot. Seasonal variation in exacerbations of ulcerative colitis. Scand J Gastroenterol 1993;28:95–6.
   PubMed Web of Science ®Google Scholar
• HHildebrand, YFinkel, LGrahnquist, JLindholm, AEkbom, JAskling. Changing pattern of paediatric inflammatory bowel disease in northern Stockholm 1990-2001. Gut 2003;52:1432–4.
   PubMed Web of Science ®Google Scholar
• VBinder, OBonnevie, TCGertz, PAKrasilnikoff, SVestermark, PRiis. Ulcerative colitis in children. Treatment, course, and prognosis. Scand J Gastroenterol 1973;8:161–7.
   PubMed Web of Science ®Google Scholar
• BLLindquist, GJärnerot, GWickbom. Clinical and epidemiological aspects of Crohn’s disease in children and adolescents. Scand J Gastroenterol 1984;19:502–6.
   PubMed Web of Science ®Google Scholar
• BSBentsen, BMoum, AEkbom. Incidence of inflammatory bowel disease in children in southeastern Norway: a prospective population-based study 1990-94. Scand J Gastroenterol 2002;37:540–5.
   PubMed Web of Science ®Google Scholar
• UAgnarsson, SBjörnsson, JHJóhansson, LSigurdsson. Inflammatory bowel disease in Icelandic children 1951-2010. Population-based study involving one nation over six decades. Scand J Gastroenterol 2013;48:1399–404.
   PubMed Web of Science ®Google Scholar
• ELangholz, PMunkholm, PAKrasilnikoff, VBinder. Inflammatory bowel diseases with onset in childhood. Clinical features, morbidity, and mortality in a regional cohort. Scand J Gastroenterol 1997;32:139–47.
   PubMed Web of Science ®Google Scholar
• GJärnerot, IJärnmark, KNilsson. Consumption of refined sugar by patients with Crohn’s disease, ulcerative colitis, or irritable bowel syndrome. Scand J Gastroenterol 1983;18:999–1002.
   PubMed Web of Science ®Google Scholar
• PGPersson, AAhlbom, GHellers. Crohn’s disease and ulcerative colitis. A review of dietary studies with emphasis on methodologic aspects. Scand J Gastroenterol 1987;22:385–9.
   PubMed Web of Science ®Google Scholar
• CTysk, GJärnerot. Has smoking changed the epidemiology of ulcerative colitis? Scand J Gastroenterol 1992;27:508–12.
   PubMed Web of Science ®Google Scholar
• PGPersson, GHellers, AAhlbom. Use of oral moist snuff and inflammatory bowel disease. Int J Epidemiol 1993;22:1101–3.
   PubMed Web of Science ®Google Scholar
• OBergstrand, GHellers. Breast-feeding during infancy in patients who later develop Crohn’s disease. Scand J Gastroenterol 1983;18:903.
   PubMed Web of Science ®Google Scholar
• HHildebrand, PMalmborg, JAskling, AEkbom, SMMontgomery. Early-life exposures associated with antibiotic use and risk of subsequent Crohn’s disease. Scand J Gastroenterol 2008;43:961–6.
   PubMed Web of Science ®Google Scholar
• TGilat, DHacohen, PLilos, MJLangman. Childhood factors in ulcerative colitis and Crohn’s disease. An international cooperative study. Scand J Gastroenterol 1987;22:1009–24.
   PubMed Web of Science ®Google Scholar
• REAndersson, GOlaison, CTysk, AEkbom. Appendectomy and protection against ulcerative colitis. N Engl J Med 2001;344:808–14.
   PubMed Web of Science ®Google Scholar
• MFrisch, BVPedersen, REAndersson. Appendicitis, mesenteric lymphadenitis, and subsequent risk of ulcerative colitis: cohort studies in Sweden and Denmark. BMJ 2009;338.
   PubMed Web of Science ®Google Scholar
• UMonsén, OBroström, BNordenvall, JSörstad, GHellers. Prevalence of inflammatory bowel disease among relatives of patients with ulcerative colitis. Scand J Gastroenterol 1987;22:214–18.
   PubMed Web of Science ®Google Scholar
• MOrholm, PMunkholm, ELangholz, OHNielsen, TISørensen, VBinder. Familial occurrence of inflammatory bowel disease. N Engl J Med 1991;324:84–8.
   PubMed Web of Science ®Google Scholar
• CTysk, ELindberg, GJärnerot, BFlodérus-Myrhed. Ulcerative colitis and Crohn’s disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 1988;29:990–6.
   PubMed Web of Science ®Google Scholar
• JHalfvarson, TJess, AMagnuson, SMMontgomery, MOrholm, CTysk, et al. Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population. Inflamm Bowel Dis 2006;12:925–33.
   PubMed Web of Science ®Google Scholar
• ENurmi, JHaapamäki, EPaavilainen, ARantanen, MHillilä, PArkkila. The burden of inflammatory bowel disease on health care utilization and quality of life. Scand J Gastroenterol 2013;48:51–7.
   PubMed Web of Science ®Google Scholar
• PBlomqvist, AEkbom. Inflammatory bowel diseases: health care and costs in Sweden in 1994. Scand J Gastroenterol 1997;32:1134–9.
   PubMed Web of Science ®Google Scholar
• MNeovius, EVArkema, PBlomqvist, AEkbom, KESmedby. Patients with ulcerative colitis miss more days of work than the general population, even following colectomy. Gastroenterology 2013;144:536–43.
   PubMed Web of Science ®Google Scholar
• ROpheim, TBernklev, MSFagermoen, MCvancarova, BMoum. Use of complementary and alternative medicine in patients with inflammatory bowel disease: results of a cross-sectional study in Norway. Scand J Gastroenterol 2012;47:1436–47.
   PubMed Web of Science ®Google Scholar
• ROlsson, JLindberg, OWeiland, LNilsson; Members of the Swedish Internal medicine Liver Club. Chronic active hepatitis in Sweden. The etiologic spectrum, clinical presentation, and laboratory profile. Scand J Gastroenterol 1988;23:463–70.
   PubMed Web of Science ®Google Scholar
• KSjöberg, SLindgren, SEriksson. Frequent occurence on non-specifik gliadin antibodies in chronic liver disease. Scand J Gastroenterol 1997;32:1162–7.
   PubMed Web of Science ®Google Scholar
• SLindgren, H-BBraun, GMichel, ANemeth, SNilsson, BThome-Kromer, et al. Absence of LKM-1 antibody reactivity in autoimmune and hepatitis C-related chronic liver disease in Sweden. Scand J Gastroenterol 1997;32:175–8.
   PubMed Web of Science ®Google Scholar
• SLindgren, SNilsson, LNässberger, HVerbaan, JWieslander. Antineutrophil cytoplasmic antibodies in patients with chronic liver diseases: Prevalence, antigen specificity and predictive value for diagnosis of autoimmune liver disease. J Gastroenterol Hepatol 2000;15:437–42.
   PubMed Web of Science ®Google Scholar
• KMBoberg, EAadland, JJahnsen, NRaknerud, MStiris, HBell. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol 1998;33:99–103.
   PubMed Web of Science ®Google Scholar
• MWerner, HPrytz, BOhlsson, SAlmer, EBjörnsson, ABergquist, et al. Epidemiology and the intial presentation of autoimmune hepatitis type 1 in Sweden. A nationwide study. Scand J Gastroenterol 2008;43:1232–40.
   PubMed Web of Science ®Google Scholar
• MWerner, SWallerstedt, SLindgren, SAlmer, EBjörnsson, ABergquist, et al. Characteristics and long-term outcome of patients with autoimmune hepatitis related to the initial treatment response. Scand J Gastroenterol 2010;45:457–67.
   PubMed Web of Science ®Google Scholar
• ÅDanielsson Borssén, SAlmer, HPrytz, SWallerstedt, ILFriis-Liby, ABergquist, et al. Hepatocellular and extrahepatic cancer in patients with autoimmune hepatitis - a long-term follow-up study in 634 Swedish patients. Scand J Gastroenterol 2015;50:217–23.
   PubMed Web of Science ®Google Scholar
• LGrønbæk, HVilstrup, PJepsen. Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study. J Hepatol 2014;60:612–17.
   PubMed Web of Science ®Google Scholar
• UBroomé, ROlsson, ÅDanielsson, LLööf, GBodemar, RHultcrantz, et al. Natural history and prognostic factors in 305 swedish patients with primary sclerosing cholangitis. Gut 1996;38:610–15.
   PubMed Web of Science ®Google Scholar
• ROlsson, ÅDanielsson, GJärnerot, ELindström, LLööf, PRolny, et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. An epidemiological study from five areas in Sweden. Gastroenterology 1991;100:1319–23.
   PubMed Web of Science ®Google Scholar
• KKJørgensen, KGrzyb, KELundin, OPClausen, GAamodt, et al. Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients. Inflamm Bowel Dis 2012;18:536–45.
   PubMed Web of Science ®Google Scholar
• ABergquist, SMMontgomery, SBahmanyar, ROlsson, ADanielsson, SLindgren, et al. Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol 2008;6:939–43.
   PubMed Web of Science ®Google Scholar
• ABergquist, AEkbom, ROlsson, DKornfeldt, LLööf, ÅDanielsson, et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 2002;36:321–7.
   PubMed Web of Science ®Google Scholar
• MBde Valle, EBjörnsson, BLindkvist. Mortality and cancer risk related to primary sclerosing cholangitis in a Swedish population-based cohort. Liver Int 2012;32:441–8I.
   PubMed Web of Science ®Google Scholar
• IMAndersen, GTengesdal, BALie, KMBoberg, THKarlsen, JRHov. Effects of coffee consumption, smoking, and hormones on risk for primary sclerosing cholangitis. Clin Gastroenterol Hepatol 2014;12:1019–28.
   PubMed Web of Science ®Google Scholar
• EBjörnsson, KMBoberg, SCullen, KFleming, OPClausen, OFausa, et al. Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis. Gut 2002;51:731–5.
   PubMed Web of Science ®Google Scholar
• UBroome, HGlaumann, ELindstom, LLoof, SAlmer, HPrytz, et al. Natural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC). J Hepatol 2002;36:586–9.
   PubMed Web of Science ®Google Scholar
• EBjörnsson, ROlsson, ABergquist, SLindgren, BBraden, RWChapman, et al. The natural history of small-duct primary sclerosing cholangitis. Gastroenterology 2008;134:975–80.
   PubMed Web of Science ®Google Scholar
• BLindkvist, MDe Valle, EBjörnsson. Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden. Hepatology 2010;52:571–7.
   PubMed Web of Science ®Google Scholar
• SEriksson, SLindgren. The prevalence and clinical spectrum of primary biliary cirrhosis in a defined population. Scand J Gastroenterol 1984;19:971–6.
   PubMed Web of Science ®Google Scholar
• JLöfgren, GJärnerot, DDanielsson, IHemdal. Incidence and prevalence of primary biliary cirrhosis in a defined population in Sweden. Scand J Gastroenterol 1985;20:647–50.
   PubMed Web of Science ®Google Scholar
• ADanielsson, LBoqvist, PUddenfeldt. Epidemiology of primary biliary cirrhosis in a defined rural population in the northern part of Sweden. Hepatology 1990;11:458–64.
   PubMed Web of Science ®Google Scholar
• MIPrince, OFJames. The epidemiology of primary biliary cirrhosis. Clin Liver Dis 2003;7:795–819.
   PubMedGoogle Scholar
• KDLindor, MEGershwin, RPoupon, MKaplan, NVBergasa, EJHeathcote; American Association for Study of Liver Diseases. Primary biliary cirrhosis. Hepatology 2009;50:291–308.
   PubMed Web of Science ®Google Scholar
• HLiu, YLiu, LWang, DXu, BLin, RZhong, et al. Prevalence of primary biliary cirrhosis in adults referring hospital for annual health check-up in Southern China. BMC Gastroenterol 2010;10:100.
   PubMed Web of Science ®Google Scholar
• HRautiainen, VSalomaa, SNiemelå, ALKarvonen, HNurmi, HIsoniemi, et al. Prevalence and incidence of primary biliary cirrhosis are increasing in Finland. Scand J Gastroenterol 2007;42:1347–53.
   PubMed Web of Science ®Google Scholar
• TRBaldursdottir, OMBergmann, JGJonasson, BRLudviksson, ESBjörnsson. Epidemiology and the natural history of primary biliary cirrhosis: a nationwide population based study. Eur J Gastroenterol Hepatol 2012;24:824–30.
   PubMed Web of Science ®Google Scholar
• WRKim, KDLindor, GRLocke3rd, TMTherneau, HAHomburger, KPBatts, et al. Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology 2000;119:1631–6.
   PubMed Web of Science ®Google Scholar
• RPMyers, AAShaheen, AFong, KWBurak, AWan, MGSwain, et al. Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: a population-based study. Hepatology 2009;50:1884–92.
   PubMed Web of Science ®Google Scholar
• OFJames, RBhopal, DHowel, JGray, ADBurt, JVMetcalf. Primary biliary cirrhosis once rare, now common in the United Kingdom? Hepatology 1999;30:390–4.
   PubMed Web of Science ®Google Scholar
• MPrince, AChetwynd, WNewman, JVMetcalf, OFJames. Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years. Gastroenterology 2002;123:1044–51.
   PubMed Web of Science ®Google Scholar
• LLööf, H-OAdami, PSparén, ÅDanielsson, LSEriksson, RHultcrantz, et al. Cancer risk in Primary Biliary Cirrhosis. A population based study from Sweden. Hepatology 1994;20:101–4.
   PubMed Web of Science ®Google Scholar
• EChristensen, LFauerholdt, PSchlichting, EJuhl, HPoulsen, NTygstrup. Aspects of the natural history of gastrointestinal bleeding in cirrhosis and the effect of prednisone. Gastroenterology 1981;81:944–52.
   PubMed Web of Science ®Google Scholar
• AGunnarsdottir, ROlsson, EBjörnsson. Characteristics and outcome of patients with esophageal varices in Sweden 1994-1997. Scand J Gastroenterol 2005;40:1462–146.
   PubMed Web of Science ®Google Scholar
• TPAlmdal, TISørensen. Incidence of parenchymal liver diseases in Denmark, 1981 to 1985: analysis of hospitalization registry data. The Danish Association for the Study of the Liver. Hepatology 1991;13:650–5.
   PubMed Web of Science ®Google Scholar
• SOlafsson, EBjörnsson. Differences and similarities in the etiology and the incidence of cirrhosis in the Nordic countries. Scand J Gastroenterol 2013;48:509–10.
   PubMed Web of Science ®Google Scholar
• JWHaukeland, ILorgen, LTSchreiner, SOFrigstad, BBrandsaeter, KBjøro, et al. Incidence rates and causes of cirrhosis in a Norwegian population. Scand J Gastroenterol 2007;42:1501–8.
   PubMed Web of Science ®Google Scholar
• SAGunnarsdottir, ROlsson, SOlafsson, NCariglia, JWestin, BThjodleifsson, et al. Liver cirrhosis in Iceland and Sweden: incidence, etiology and outcomes. Scand J Gastroenterol 2009;44:984–93.
   PubMed Web of Science ®Google Scholar
• DLudviksdóttir, HSkúlason, FJakobsson, AThórisdóttir, NCariglia, BMagnússon, et al. Epidemiology of liver cirrhosis morbidity and mortality in Iceland. Eur J Gastroenterol Hepatol 1997;9:61–6.
   PubMed Web of Science ®Google Scholar
• ADam Fialla, OBSchaffalitzky de Muckadell, ATouborg Lassen. Incidence, etiology and mortality of cirrhosis: a population-based cohort study. Scand J Gastroenterol 2012;47:702–9.
   PubMed Web of Science ®Google Scholar
• PJepsen, HVilstrup, HTSørensen. Alcoholic cirrhosis in Denmark - population-based incidence, prevalence, and hospitalization rates between 1988 and 2005: a descriptive cohort study. BMC Gastroenterol 2008;8:3.
   Web of Science ®Google Scholar
• TDeleuran, HVilstrup, UBecker, PJepsen. Epidemiology of Alcoholic Liver Disease in Denmark 2006-2011: A Population-Based Study. Alcohol Alcohol 2015. [Epub ahead of print].
   PubMedGoogle Scholar
• KStokkeland, LBrandt, AEkbom, UOsby, RHultcrantz. Morbidity and mortality in liver diseases in Sweden 1969-2001 in relation to alcohol consumption. Scand J Gastroenterol 2006;41:459–64.
   PubMed Web of Science ®Google Scholar
• KStokkeland, LBrandt, AEkbom, RHultcrantz. Improved prognosis for patients hospitalized with esophageal varices in Sweden 1969-2002. Hepatology 2006;43:500–5.
   PubMed Web of Science ®Google Scholar
• JSand, AVälikoski, INordback. Alcohol consumption in the country and hospitalizations for acute alcohol pancreatitis and liver cirrhosis during a 20-year period. Alcohol Alcohol 2009;44:321–5.
   PubMed Web of Science ®Google Scholar
• TTyrfingsson, SOlafsson, ESBjornsson, VRafnsson. Alcohol consumption and liver cirrhosis mortality after lifting ban on beer sales in country with state alcohol monopoly. Eur J Public Health 2014; Epub ahead of print.
   PubMed Web of Science ®Google Scholar
• EBjörnsson, JOlsson, RRydell, KFredriksson, CEriksson, CSjöberg, et al. Long-term follow-up of patients with alcoholic liver disease after liver transplantation in Sweden: impact of structured management on recidivism. Scand J Gastroenterol 2005;40:1–11.
   PubMed Web of Science ®Google Scholar
• MDossing, PBAndreasen. Drug-induced liver disease in Denmark. An analysis of 572 cases of hepatotoxicity reported to the Danish board of adverse reactions to drugs. Scand J Gastroenterol 1982;17:205–11.
   PubMed Web of Science ®Google Scholar
• HFriis, PBAndreasen. Drug-induced hepatic injury: an analysis of 1100 cases reported to the Danish Committee on Adverse Drug Reactions between 1978 and 1987. J Intern Med 1992;232:133–8.
   PubMed Web of Science ®Google Scholar
• BBjörnsson, ABergqvist, PJerlstad, ROlsson. Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden. Scand J Gastroenterol 2005;40:1095–101.
   PubMed Web of Science ®Google Scholar
• EBjörnsson, ROlsson. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology 2005;42:481–9.
   PubMed Web of Science ®Google Scholar
• ROlsson, BEWiholm, CSand, LZettergren, RHultcrantz, MMyrhed. Liver damage from flucloxacillin, cloxacillin and dicloxacillin. J Hepatol 1992;15:154–61.
   PubMed Web of Science ®Google Scholar
• ALindgren, ROlsson. Liver damage from low-dose oral contraceptives. J Intern Med 1993;234:287–92.
   PubMed Web of Science ®Google Scholar
• ALindgren, ROlsson. Liver reactions from trimethoprim. J Intern Med 1994;236:281–4.
   PubMed Web of Science ®Google Scholar
• EBjörnsson, JLindberg, ROlsson. Liver reactions to oral low-dose tetracyclines. Scand J Gastroenterol 1997;32:390–5.
   PubMed Web of Science ®Google Scholar
• EBjörnsson, HNordlinder, ROlsson. Clinical characteristics and prognostic markers in Disulfiram-induced liver injury. J Hepatol 2006;44:791–7.
   PubMed Web of Science ®Google Scholar
• EBjörnsson, ROlsson. Serious adverse liver reactions associated with herbal weight loss supplements. J Hepatol 2007;47:295–7.
   PubMed Web of Science ®Google Scholar
• EBjörnsson, EIJacobsen, EKalaitzakis. Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing. J Hepatol 2012;56:374–80.
   PubMed Web of Science ®Google Scholar
• Mde Valle, VKlinteberg, NAlem, ROlsson, EBjörnsson. Drug-induced liver injury in a Swedish University hospital outpatient hepatology clinic. Aliment Pharmacol Ther 2006;24:1187–95.
   PubMed Web of Science ®Google Scholar
• EBjörnsson, EKalaitzakis, VAv Klinteberg, NAlem, ROlsson. Long-term follow-up in patients with mild to moderate drug-induced liver injury. Aliment Pharmacol Ther 2007;26:79–85.
   PubMed Web of Science ®Google Scholar
• EBjörnsson, LDavidsdottir. The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice. J Hepatol 2009;50:511–17.
   PubMed Web of Science ®Google Scholar
• IKjartansdottir, OMBergmann, RArnadottir, EBjornsson. Paracetamol intoxications:a retrospective population-based study in Iceland. Scand J Gastroenterol 2012;47:1344–52.
   PubMed Web of Science ®Google Scholar
• OMBergmann, GKristjansson, JGJonasson, ESBjörnsson. Jaundice due to suspected statin hepatotoxicity: a case series. Dig Dis Sci 2012;57:1959–64.
   PubMed Web of Science ®Google Scholar
• ESBjörnsson, BIGunnarsson, GGröndal, JGJonasson, REinarsdottir, BRLudviksson, et al. The risk of drug-induced liver injury from tumor necrosis factor (TNF)-alpha-antagonists. Clin Gastroenterol Hepatol 2014;S1542-3565:01151–3.
   Google Scholar
• ESBjornsson, OMBergmann, HKBjornsson, RBKvaran, SOlafsson. Incidence, presentation and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology 2013;144:1419–25.
   PubMed Web of Science ®Google Scholar
• ARopponen, RSund, SRiikonen, OYlikorkala, KAittomaki. Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population based study. Hepatology 2006;43:723–8.
   PubMed Web of Science ®Google Scholar
• HUMarschall, EWikstöm Shermer, JFLudvigsson, OStephansson. Intrahepatic cholestasis of pregnancy and associated hepatobiliary disease. Hepatology 2013;58:1385–91.
   PubMed Web of Science ®Google Scholar
• RRajani, TMelin, EBjörnsson, UBroomé, PSangfelt, ÅDanielsson, et al. Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival – an 18 year experience. Liver Int 2009;29:253–9.
   PubMed Web of Science ®Google Scholar
• RRajani, EBjörnsson, ABergquist, ÅDanielsson, AGustavsson, OGrip, et al. Epidemiology and clinical features of portal vein thrombosis: a multicenter study. Aliment Pharmacol Ther 2010;32:1154–62.
   PubMed Web of Science ®Google Scholar
• MElmberg, RHultcrantz, AEkbom, LBrandt, KSOlsson, ROlsson, et al. Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives. Gastroenterology 2003;125:1733–41.
   PubMed Web of Science ®Google Scholar
• MElmberg, RHultcrantz, EFereshte, SOlsson, SLindgren, LLööf, et al. Increased mortality risk in patients with phenotypic hereditary hemochromatosis but not in their first-degree relatives. Gastroenterology 2009;137:1301–9.
   PubMed Web of Science ®Google Scholar
• AAsberg, KHveem, KThorstensen, EEllekjter, KKannelønning, UFjøsne, et al. Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol 2001;36:1108–15.
   PubMed Web of Science ®Google Scholar
• AAsberg, KHveem, OKrüger, KSBjerve. Persons with screening-detected haemochromatosis: as healthy as the general population? Scand J Gastroenterol 2002;37:719–24.
   PubMed Web of Science ®Google Scholar
• ASDuberg, HPettersson, SAleman, ABlaxhult, LDaviðsdóttir, RHultcrantz. The burden of hepatitis C in Sweden: a national study of inpatient care. J Viral Hepat 2011;18:106–18.
   PubMed Web of Science ®Google Scholar
• GWei, ABergquist, UBroomé, SLindgren, SWallerstedt, SAlmer, et al. Acute liver failure in Sweden: etiology and outcome. J Intern Med 2007;262:393–401.
   PubMed Web of Science ®Google Scholar
• WMLee. Acute liver failure in the United States. Semin Liver Dis 2003;23:217–26.
   PubMed Web of Science ®Google Scholar
• GWei, EKalaitzakis, ABergquist, EBjörnsson. Long-term follow-up of patients with acute liver failure of indeterminite etiology. Scand J Gastroenterol 2008;43:984–91.
   PubMed Web of Science ®Google Scholar
• OBonnevie. The incidence of duodenal ulcer in Copenhagen county. Scand J Gastroenterol 1975;10:385–93.
   PubMed Web of Science ®Google Scholar
• OBonnevie. The incidence of gastric ulcer in Copenhagen county. Scand J Gastroenterol 1975;10:231–9.
   PubMed Web of Science ®Google Scholar
• SJRosenstock, TJørgensen. Prevalence and incidence of peptic ulcer disease in a Danish County–a prospective cohort study. Gut 1995;36:819–24.
   PubMed Web of Science ®Google Scholar
• LKay, TJørgensen, KHJensen. Epidemiology of abdominal symptoms in a random population: prevalence, incidence, and natural history. Eur J Epidemiol 1994;10:559–66.
   PubMed Web of Science ®Google Scholar
• LKay, TJørgensen, KHJensen. The epidemiology of irritable bowel syndrome in a random population: prevalence, incidence, natural history and risk factors. J Intern Med 1994;236:23–30.
   PubMed Web of Science ®Google Scholar
• LKay, TJørgensen. Epidemiology of upper dyspepsia in a random population. Prevalence, incidence, natural history, and risk factors. Scand J Gastroenterol 1994;29:2–6.
   PubMed Web of Science ®Google Scholar
• LBOlafsdottir, HGudjonsson, HHJonsdottir, EBjornsson, BThjodleifsson. Natural history of functional gastrointestinal disorders: comparison of two longitudinal population-based studies. Dig Liver Dis 2012;44:211–17.
   PubMedGoogle Scholar
• LOlafsdottir, EBjörnsson, BThjodleifsson, HJonsdottir, HGudjonsson. Natural history of irritable bowel syndrome in women and dysmenorrhea: a 10-year follow up study. Gastroenterol Res Pract 2012;2012:534204.
   PubMedGoogle Scholar
• LAgréus, KSvärdsudd, NJTalley, MPJones, GTibblin. Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol 2001;96:2905–14.
   PubMed Web of Science ®Google Scholar
• MNilsson, RJohnsen, WYe, KHveem, JLagergren. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA 2003;290:66–72.
   PubMed Web of Science ®Google Scholar
• MNilsson, RJohnsen, WYe, KHveem, JLagergren. Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux. Gut 2004;53:1730–5.
   PubMed Web of Science ®Google Scholar
• MNilsson, RJohnsen, WYe, KHveem, JLagergren. Prevalence of gastro-oesophageal reflux symptoms and the influence of age and sex. Scand J Gastroenterol 2004;39:1040–5.
   PubMed Web of Science ®Google Scholar
• JRonkainen, PAro, TStorskrubb, SEJohansson, TLind, EBolling-Sternevald. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol 2005;40:275–85.
   PubMed Web of Science ®Google Scholar
• MHeikkinen, MFärkkilä. Long-term outcome of functional dyspepsia: effect of Helicobacter pylori infection. A 6- to 7-year follow-up study. Scand J Gastroenterol 2002;37:905–10.
   PubMed Web of Science ®Google Scholar
• HNordenstedt, MNilsson, RJohnsen, JLagergren, KHveem. Helicobacter pylori infection and gastroesophageal reflux in a population-based study (The HUNT Study). Helicobacter 2007;12:16–22.
   PubMed Web of Science ®Google Scholar